Alcon Trying to Engineer Aurion ‘Fire Sale,’ Says Suit (Correct)

Alcon Research LLC is trying to engineer a cheap acquisition of Aurion Biotech Inc. by blocking Aurion’s other funding options and improperly gaining influence on its board, Aurion investors claim in a lawsuit.

The investors—two funds affiliated with Deerfield Management Co.—filed their complaint in Delaware’s Chancery Court Monday. They allege Alcon has waged an “unrelenting campaign” to orchestrate a “fire sale” of biotechnology company Aurion to Alcon, the world’s largest eye care company.

After Aurion rejected Alcon’s proposals, Alcon delayed Aurion’s planned public offering through litigation, the complaint says. The eye care company then entered into an agreement with ...